{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "North Brunswick",
      "state": "NJ",
      "country": "United States",
      "classification": "Class III",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "71973",
      "recalling_firm": "Ohm Laboratories, Inc.",
      "address_1": "1385 Livingston Ave",
      "address_2": "N/A",
      "postal_code": "08902-1829",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide.",
      "recall_number": "D-0036-2016",
      "product_description": "Up&Up loratadine orally disintegrating tablets, USP, 10 mg, 30-count tablets per box,  Distributed by Target Corp, Minneapolis, MN  55403; NDC 11673-527-31, UPC 3 5166052731 5",
      "product_quantity": "34,488 boxes",
      "reason_for_recall": "Superpotent Drug: Out Of Specification (OOS) result for Assay.",
      "recall_initiation_date": "20150728",
      "center_classification_date": "20151015",
      "termination_date": "20161028",
      "report_date": "20151021",
      "code_info": "Batch Numbers:  2617892, 2617893, Exp 5/31/2016; 2625092, 2625093, Exp 6/30/2016;  2658137, 2658138, Exp 11/30/2016"
    }
  ]
}